Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

News · October 17, 2023

EASD 2023: Testosterone Replacement Therapy Improves Glycemic Control in Type 2 Diabetes

Findings from real-world data of ongoing study show reduction in HbA1c at three, 12, and 24 months

PracticeUpdate Editorial Team


Further Reading